HPV-Associated Cancers and Precancers
10 questions
Learning Objectives
- Discuss the epidemiology of human papilloma virus-related cervical, anal, and oropharyngeal cancers in the United States
- Summarize recommendations for cervical cancer screening in terms of age, HIV status, and clinical indicators
- Provide a rationale for Papanicolaou and human papillomavirus cotesting
- State the recommendations for routine anal cancer screening in men with or without HIV infection
Authors
Helen C. Stankiewicz Karita, MD
Helen C. Stankiewicz Karita, MD
Associate Professor of Medicine
University of California at San Francisco
Associate Professor of Medicine
University of California at San Francisco
Disclosures: None
Michelle C. Sabo, MD, PhD
Michelle C. Sabo, MD, PhD
Acting Assistant Professor
Division of Allergy and Infectious Diseases
University of Washington
Acting Assistant Professor
Division of Allergy and Infectious Diseases
University of Washington
Disclosures: None
Reviewers
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Editor-in-Chief, National STD Curriculum
Division of Allergy and Infectious Diseases
University of Washington
Professor of Medicine
Editor-in-Chief, National STD Curriculum
Division of Allergy and Infectious Diseases
University of Washington
Disclosures: None
2nd Edition
This is the first time this Question Bank Topic appears on the National STD Curriculum.
CNE/CME Continuing Education
This question bank topic qualifies for:
View CE Notices | View CME+MOC Notice
- 1 CME AMA PRA Category 1 Credit™, 1 MOC Part II Point, or
- 1 CNE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: October 21st, 2022
CNE and CME Expiration: October 20th, 2025 (2nd Edition)
View CE Notices | View CME+MOC Notice
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME+MOC
4
Give Feedback
Complete survey
5